http://www.coherus.com
Coherus BioSciences, Inc. Company Intro
Coherus is a leading global biosimilar company. We are committed to improving patient lives by expanding access to life-changing biologic medicines.
Industry
Healthcare
Coherus BioSciences, Inc. Headquaters
333 Twin Dolphin Drive
Redwood City,94065
United States
Coherus BioSciences, Inc. Share price
23 Oct 2020 01:20 GMT
$16.50
-0.06 (-0.36 %)
Coherus BioSciences, Inc. Market cap
$1.215 B
WMC RANKING
2020
Coherus BioSciences, Inc. # 16
BiotechnologyLatest Coherus BioSciences, Inc. News
22 Oct 2020
Behcet Disease Drug Market Analysis, Size, Regional Outlook ...
... firms such as AbbVie Inc, R Pharm, Coherus BioSciences Inc, Celgene Corp, ... The company's present position in the Behcet Disease Drug market in ...
22 Oct 2020
Biosimilars Market Evolving Industry Trends and Key Insights ...
The key players studied in the report include: Coherus BioSciences, Pfizer, Amgen Inc., Mylan N.V., Certolizumab pegol traded as CIMZIA. Get a sample of the ...
22 Oct 2020
Biosimilars Market Evolving Industry Trends and Key Insights ...
The key players studied in the report include: Coherus BioSciences, Pfizer, Amgen Inc., Mylan N.V., Certolizumab pegol traded as CIMZIA. Get a sample of the ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Coherus BioSciences, Inc. | 4.19 | 6.08 | 6.52 | 0 | 0 | 0 | 9.43 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.22 | 100 | 19 | 0 | 0 | 98.82 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.11 | 30 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 3.02 |
| Incyte Corporation | 40.27 | 14.26 | 7.25 | 100 | 0 | 0 | 90.92 |
Coherus BioSciences, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Coherus BioSciences, Inc. | $232,215 | $220,709 | $-11,990 | $1.215B | 16 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $26.228B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $54.719B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.699B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.79B | 4 |